1. Home
  2. PL vs ABVX Comparison

PL vs ABVX Comparison

Compare PL & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Planet Labs PBC

PL

Planet Labs PBC

HOLD

Current Price

$36.69

Market Cap

10.9B

Sector

Industrials

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$118.36

Market Cap

9.7B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PL
ABVX
Founded
2010
2013
Country
United States
France
Employees
970
67
Industry
Aerospace
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.9B
9.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PL
ABVX
Price
$36.69
$118.36
Analyst Decision
Buy
Buy
Analyst Count
12
13
Target Price
$27.64
$131.31
AVG Volume (30 Days)
10.6M
756.8K
Earning Date
06-03-2026
03-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$42.29
$52.14
Revenue Next Year
$30.22
$4,132.27
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.38
$5.59
52 Week High
$41.71
$148.83

Technical Indicators

Market Signals
Indicator
PL
ABVX
Relative Strength Index (RSI) 56.04 51.89
Support Level $31.88 $107.55
Resistance Level $37.63 $129.84
Average True Range (ATR) 3.04 5.17
MACD -0.44 -0.26
Stochastic Oscillator 49.64 54.38

Price Performance

Historical Comparison
PL
ABVX

About PL Planet Labs PBC

Planet Labs PBC is an Earth-imaging company. It uses space to help life on Earth by imaging the world every day and making change visible, accessible, and actionable. Its platform includes imagery, insights, and machine learning that empower companies, governments, and communities around the world to make timely decisions about the evolving world. Its solutions are Broad Area Management. Its products are Planet Monitoring, Planet Tasking, Planet Analytic Feeds, Planetary Variables, Planet Basemaps, Planet Insights, and Platform Pricing. The group provides solutions to the Agriculture Science Program, Energy & Infrastructure, Forestry & Land Use, Mapping, Sustainability, Maritime, Civil Government, U.S. State and Local, Europe, Planet Federal, Defense & Intelligence, and Armed Services.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: